ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

Reuters

2025/08/02

ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast

ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, "Resmed has a long-standing track record of engaging constructively with the US government." The full transcript can be accessed through the link below.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2556884217"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2556884217\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2556884217?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-02 10:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2556884217","market":"us","top_or_hot":-1,"title":"ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a>, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-02 10:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and <a href=\"https://laohu8.com/S/MTK\">Morgan Stanley</a>, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMD","symbol_name":"瑞思迈","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250802:nNDL3BDh5j:1","article_id":"2556884217","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2556884217","pubTimestamp":1754101733,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be acce","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"RMD":"瑞思迈"},"translate_title":"ResMed Inc.发布2025财年收益网络广播记录","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMD":0.9},"content_text":"ResMed Inc. Releases Transcript of FY 2025 Earnings Webcast\n    \n\n        ResMed Inc. recently released the transcript of its Q4 fiscal year 2025 earnings call, held on July 31, 2025. The event, webcast live from Sydney, was hosted by Salli Schwartz, ResMed's Chief Investor Relations Officer, and featured key executives, including CEO Michael Farrell and CFO Brett Sandercock. Analysts from various financial institutions, such as RBC Capital Markets, Goldman Sachs, and Morgan Stanley, participated in the conference call. During the call, ResMed's management discussed the company's ongoing focus on its core business of helping over 2.3 billion people worldwide with sleep apnea, insomnia, and respiratory insufficiency. The executives emphasized the company's commitment to healthcare delivery through its market-leading software. They also touched upon the potential resumption of the competitive bidding program by CMS, with the CEO stating, \"Resmed has a long-standing track record of engaging constructively with the US government.\" The full transcript can be accessed through the link below.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ResMed Inc. published the original content used to generate this news brief on August 02, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}